Patient testimonials CML Chronic Myeloid Leukemia
Bud Romine was the first patient in the world starting to take Gleevec in June 25, 1998
Suzan Mc Namara is the patient who started a petition to Novartis which is a corporation that produced pills for clinical trials conducted by Dr. Druker for CML patients. Later, she received a phone call from Dr. Druker at her birthday (November 2, 1999), saying that Novartis has planned to speed up production
Suzan Mc Namara is the patient who started a petition to Novartis which is a corporation that produced pills for clinical trials conducted by Dr. Druker for CML patients. Later, she received a phone call from Dr. Druker at her birthday (November 2, 1999), saying that Novartis has planned to speed up production
Attention
To access this module, you need to get your CMLer's password. This password stay active for all the session on the website.
To access this module, you need to get your CMLer's password. This password stay active for all the session on the website.
Modes of access to the website
1 - Public access (strongly recommended)
On several occasions, the CML patient called CMLer will need a password to access several modules of the website. .
(No registration required - Anonymous access)
1 - Public access (strongly recommended)
On several occasions, the CML patient called CMLer will need a password to access several modules of the website. .
(No registration required - Anonymous access)
2 - Reserved access to CMLeukemia private group
On other occasions, the more experienced patients need more up-to-date or in-depth information. Among other upcoming modules, they will need access to the archives and also to abstracts of congresses on CML.
(Member password required and registration required).
On other occasions, the more experienced patients need more up-to-date or in-depth information. Among other upcoming modules, they will need access to the archives and also to abstracts of congresses on CML.
(Member password required and registration required).
